Lipocine's postpartum depression drug fails; AstraZeneca claims liver cancer win
Lipocine's postpartum depression drug fails; AstraZeneca claims liver cancer win
Lipocine's postpartum depression drug fails; AstraZeneca claims liver cancer win
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.